In the cecal ligation and puncture (CLP) model of sepsis, PPAR-γ agonist ameliorates systemic inflammation by decreasing plasma levels of TNF-α and IL-6 via inhibition of nuclear factor kappa B (NF-κB) [15, 16]. Here, TNF is linked to Sepsis.